Radiolabeled, Antibody-Conjugated Manganese Oxide Nanoparticles for Tumor Vasculature Targeted Positron Emission Tomography and Magnetic Resonance Imaging
文献类型:期刊论文
作者 | Zhan, Yonghua1; Shi, Sixiang2; Ehlerding, Emily B.3; Graves, Stephen A.3; Goel, Shreya2; Engle, Jonathan W.3; Liang, Jimin1; Tian, Jie5![]() |
刊名 | ACS APPLIED MATERIALS & INTERFACES
![]() |
出版日期 | 2017-11-08 |
卷号 | 9期号:44页码:38304-38312 |
关键词 | Manganese Oxide Nanoparticles Cancer Positron Emission Tomography (Pet) Magnetic Resonance Imaging (Mri) Cd105 (Endoglin) |
DOI | 10.1021/acsami.7b12216 |
文献子类 | Article |
英文摘要 | Manganese oxide nanoparticles (Mn3O4 NPs) have attracted a great deal of attention in the field of biomedical imaging because of their ability to create an enhanced imaging signal in MRI as novel potent T-1 contrast agents. In this study, we present tumor vasculature-targeted imaging in mice using Mn3O4 NPs through conjugation to the anti-CD105 antibody TRC105 and radionuclide copper-64 (Cu-64, t(1/2): 12.7 h). The Mn3O4 conjugated NPs, Cu-64-NOTAMn(3)O(4)@PEG-TRC105, exhibited sufficient stability in vitro and in vivo. Serial positron emission tomography (PET) and magnetic resonance imaging (MRI) studies evaluated the pharmacokinetics and demonstrated targeting of Cu-64-NOTA-Mn3O4@PEG-TRC105 to 4T(1) murine breast tumors in vivo, compared to Cu-64-NOTA-Mn3O4@PEG. The specificity of Cu-64-NOTA-Mn3O4@PEG-TRC105 for the vascular marker CD105 was confirmed through in vivo, in vitro, and ex vivo experiments. Since Mn3O4 conjugated NPs exhibited desirable properties for T1 enhanced imaging and low toxicity, the tumor-specific Mn3O4 conjugated NPs reported in this study may serve as promising multifunctional nanoplatforms for precise cancer imaging and diagnosis. |
WOS关键词 | IN-VIVO ; LOW-TEMPERATURE ; DRUG-DELIVERY ; MN3O4 NANOPARTICLES ; MONOCLONAL-ANTIBODY ; MNO NANOPARTICLES ; ENDOGLIN ANTIBODY ; CONTRAST AGENTS ; MRI CONTRAST ; CANCER |
WOS研究方向 | Science & Technology - Other Topics ; Materials Science |
语种 | 英语 |
WOS记录号 | WOS:000415140800017 |
资助机构 | University of Wisconsin Madison ; National Institutes of Health(NIBIB/NCI 1R01CA169365 ; American Cancer Society(125246-RSG-13-099-01-CCE) ; National Natural Science Foundation of China(81227901 ; Natural Science Basic Research Plan in Shaanxi Province of China(2017JM8057) ; Fundamental Research Funds for the Central Universities(JB171204) ; 1R01CA205101 ; 11727813 ; 1R01EB021336 ; 81571725 ; T32GM008505 ; 81230033 ; T32CA009206 ; 31371006 ; P30CA014520) ; 61405149 ; 81660505 ; 81627807) |
源URL | [http://ir.ia.ac.cn/handle/173211/21920] ![]() |
专题 | 自动化研究所_中国科学院分子影像重点实验室 |
作者单位 | 1.Xidian Univ, Sch Life Sci & Technol, Minist Educ, Engn Res Ctr Mol & Neuro Imaging, Xian 710071, Shaanxi, Peoples R China 2.Univ Wisconsin, Dept Radiol, Madison, WI 53705 USA 3.Univ Wisconsin, Dept Med Phys, Madison, WI 53705 USA 4.Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53705 USA 5.Chinese Acad Sci, Inst Automat, Beijing 100190, Peoples R China |
推荐引用方式 GB/T 7714 | Zhan, Yonghua,Shi, Sixiang,Ehlerding, Emily B.,et al. Radiolabeled, Antibody-Conjugated Manganese Oxide Nanoparticles for Tumor Vasculature Targeted Positron Emission Tomography and Magnetic Resonance Imaging[J]. ACS APPLIED MATERIALS & INTERFACES,2017,9(44):38304-38312. |
APA | Zhan, Yonghua.,Shi, Sixiang.,Ehlerding, Emily B..,Graves, Stephen A..,Goel, Shreya.,...&Cai, Weibo.(2017).Radiolabeled, Antibody-Conjugated Manganese Oxide Nanoparticles for Tumor Vasculature Targeted Positron Emission Tomography and Magnetic Resonance Imaging.ACS APPLIED MATERIALS & INTERFACES,9(44),38304-38312. |
MLA | Zhan, Yonghua,et al."Radiolabeled, Antibody-Conjugated Manganese Oxide Nanoparticles for Tumor Vasculature Targeted Positron Emission Tomography and Magnetic Resonance Imaging".ACS APPLIED MATERIALS & INTERFACES 9.44(2017):38304-38312. |
入库方式: OAI收割
来源:自动化研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。